Seres Therapeutics, Inc. (NASDAQ ... that it has received a $50 million installment payment from Nestlé Health Science. This payment is part of the transition obligations following the sale ...

Today, Fred Hutch’s Human Biology, Public Health Sciences, Vaccine and Infectious Disease, and Translational Science and Therapeutics divisions carry on this essential work, leveraging ...

The full lineup of late-breaking clinical science to be presented at THT 2025: Technology and Heart Failure Therapeutics is now available online. Organized by the Cardiovascular Research Foundation® ...

The overall goal of the Hub is to take world-leading research to commercialisation outcomes such as spinouts and licenses. Along with Trinity, University College Dublin (UCD) and RCSI University of ...

The small trial will help to establish whether kidneys from genetically modified pigs can be transplanted into people safely and effectively.

Seres Therapeutics, Inc. (Nasdaq ... which was sold to Nestlé Health Science in September 2024. The Company is developing SER-155, which has received both Breakthrough Therapy and Fast Track ...

--(BUSINESS WIRE)--Lyndra Therapeutics, a clinical-stage biopharmaceutical ... Fisher Scientific Inc., the world leader in serving science, in which Thermo Fisher will provide global clinical ...

Jan. 28, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq ... Journal of Nephrological Science. The publication, entitled “Patient Perspectives: The Effects of Contemporary ...